Insights

Large local footprint Leverage NIZHPHARM's two domestic production sites and extensive local market focus in Russia to position for contract manufacturing partnerships, private-label opportunities, and supply chain resilience projects with national distributors and healthcare providers.

Diversified portfolio Target collaborations across OTC, dietary supplements, medical devices, and prescription segments (originals and generics) to expand product listings, co-development of new formulations, and cross-sell opportunities within hospital and community pharmacy channels.

Therapeutic depth Capitalize on strengths in cardiology, endocrinology, neurology, and reproductive health to align value propositions with payer-focused disease management programs, slide-ready evidence generation, and strategic partnerships with clinics and specialists.

Regional market presence Emphasize Russia-focused manufacturing and local needs to offer reliable supply, market-specific adaptations, and rapid delivery for partners seeking minimized import risk and compliant, locally relevant products.

Scale and sustainability Propose collaborations for expanding production capacity, improving digital marketing and analytics (aligned with tech stack tools), and exploring sustainability-driven initiatives that can attract health system customers and international partners seeking responsible manufacturers.

NIZHPHARM Group Tech Stack

NIZHPHARM Group uses 5 technology products and services including Facebook Pixel, AngularJS, Modernizr, and more. Explore NIZHPHARM Group's tech stack below.

  • Facebook Pixel
    Analytics
  • AngularJS
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • Yandex Metrica
    Web Analytics
  • Facebook
    Widgets

NIZHPHARM Group's Email Address Formats

NIZHPHARM Group uses at least 1 format(s):
NIZHPHARM Group Email FormatsExamplePercentage
First.Last@stada.ruJohn.Doe@stada.ru
99%
FirstLast@stada.ruJohnDoe@stada.ru
1%

Frequently Asked Questions

What is NIZHPHARM Group's official website and social media links?

Minus sign iconPlus sign icon
NIZHPHARM Group's official website is stada.ru and has social profiles on LinkedIn.

How much revenue does NIZHPHARM Group generate?

Minus sign iconPlus sign icon
As of July 2026, NIZHPHARM Group's annual revenue is estimated to be $10B+.

What is NIZHPHARM Group's SIC code NAICS code?

Minus sign iconPlus sign icon
NIZHPHARM Group's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does NIZHPHARM Group have currently?

Minus sign iconPlus sign icon
As of July 2026, NIZHPHARM Group has approximately 458 employees across 4 continents, including AsiaEuropeNorth America. Key team members include Ceo: O. P.Coo: M. B.Chief Information Systems Specialist: В. Е.. Explore NIZHPHARM Group's employee directory with LeadIQ.

What industry does NIZHPHARM Group belong to?

Minus sign iconPlus sign icon
NIZHPHARM Group operates in the Pharmaceutical Manufacturing industry.

What technology does NIZHPHARM Group use?

Minus sign iconPlus sign icon
NIZHPHARM Group's tech stack includes Facebook PixelAngularJSModernizrYandex MetricaFacebook.

What is NIZHPHARM Group's email format?

Minus sign iconPlus sign icon
NIZHPHARM Group's email format typically follows the pattern of First.Last@stada.ru. Find more NIZHPHARM Group email formats with LeadIQ.

When was NIZHPHARM Group founded?

Minus sign iconPlus sign icon
NIZHPHARM Group was founded in 2008.
NIZHPHARM Group logo

NIZHPHARM Group

Pharmaceutical ManufacturingMoskow, Russia201-500 Employees

NIZHPHARM Group is a Russia-based pharmaceutical manufacturer with a 105-year history and was formerly part of the STADA Group. Its operations span the OTC segment, dietary supplements, medical devices, and prescription medicines, including both original therapies and generics. The portfolio covers more than 17 therapeutic areas, with a focus on cardiology, endocrinology, neurology, and reproductive health, and about sixty percent consists of locally developed original drugs while the remainder comprises imported products. The group operates two production sites, Nizhpharm JSC in Nizhny Novgorod and Hemofarm LLC in Obninsk, supporting its emphasis on meeting local needs for partners and patients in Russia.

Headquartered in Moscow, Russia, NIZHPHARM is positioned as one of the leading manufacturers in the Russian pharmaceutical industry, serving the domestic market and maintaining a sizeable workforce.

Section iconCompany Overview

Website
stada.ru
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2008
Employees
201-500

Section iconFunding & Financials

  • $10B+

    NIZHPHARM Group's revenue is estimated to be in the range of $10B+

Section iconFunding & Financials

  • $10B+

    NIZHPHARM Group's revenue is estimated to be in the range of $10B+

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.